Search For "bharat biotech"
Government could evaluate AstraZeneca, Covaxin: Dr Vijay Bhaskar
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the indigenously researched Covaxin and AstraZeneca to address the Covid-19 pandemic, Dr Vijay Bhaskar, Chairman of the Ethics Committee, Clinical trials and research said on Thursday.
Read More
Vice President discusses status of indigenous vaccine against COVID-19
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on the Vice President M Venkaiah Naidu in Hyderabad on Friday.
Read More
Bharat Biotech bosses discuss Covaxin status with Vice-President
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President M Venkaiah Naidu at his residence on Friday in Hyderabad.
Read More
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Updated : 5 years, 3 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Read More
Bharat Biotech, Ocugen to co-develop Covaxin for United States market
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
Read More
No serious adverse effect due to the COVAXIN vaccine reveals interim findi
Updated : 5 years, 3 months ago IST
New Delhi [India], December 16 (ANI): No serious adverse effect related to the vaccine has been reported by COVID-19 vaccine (BBV152) COVAXIN, the interim finding from the phase 1 clinical trial of COVAXIN has stated which has now been published in the pre-print version on Monday.
Read More
70-80 pc reduction in COVAXIN trial participation: AIIMS doctor
Updated : 5 years, 3 months ago IST
New Delhi [India], December 16 (ANI): With the start of COVID vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per c
Read More
COVID-19 positive Anil Vij referred to Medanta Hospital in Gurugram from P
Updated : 5 years, 3 months ago IST
Rohtak (Haryana) [India], December 15 (ANI): Haryana Health Minister Anil Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' has been referred to Medanta Hospital Gurugram on Tuesday.
Read More
COVID positive Anil Vij shifted to Rohtak's PGIMS, condition stable
Updated : 5 years, 3 months ago IST
Rohtak (Haryana) [India], December 14 (ANI): Haryana Home Minister Anil Vij, who had tested positive for coronavirus on December 5, was shifted to the Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak from Ambala's civil hospital.
Read More
Covaxin to be available in the first quarter of next year, says Bharat Bio
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 9 (ANI): Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
Read More
MEA organises tour of heads of missions to Hyderabad biotech companies
Updated : 5 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Ministry of External Affairs on Wednesday organised a tour of heads of missions and their representatives to the research and manufacturing facilities of the leading biotechnology companies, Bharat Biotech and Biological E, in Hyderabad.
Read More
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 3 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More